Gardulf A - Search Results

1

Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.

Gardulf A, Nicolay U, Math D, Asensio O, Bernatowska E, Böck A, Costa-Carvalho BT, Granert C, Haag S, Hernández D, Kiessling P, Kus J, Matamoros N, Niehues T, Schmidt S, Schulze I, Borte M. Gardulf A, et al. J Allergy Clin Immunol. 2004 Oct;114(4):936-42. doi: 10.1016/j.jaci.2004.06.053. J Allergy Clin Immunol. 2004. PMID: 15480339

2

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion.

Gardulf A, Hammarström L, Smith CI. Gardulf A, et al. Lancet. 1991 Jul 20;338(8760):162-6. doi: 10.1016/0140-6736(91)90147-h. Lancet. 1991. PMID: 1712881 Clinical Trial.

3

Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency.

Gardulf A, Björvell H, Gustafson R, Hammarström L, Smith CI. Gardulf A, et al. Immunodeficiency. 1993;4(1-4):81-4. Immunodeficiency. 1993. PMID: 7513227 No abstract available.

4

Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy.

Gardulf A, Björvell H, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Nyström T, Søeberg B, et al. Gardulf A, et al. J Adv Nurs. 1995 May;21(5):917-27. doi: 10.1046/j.1365-2648.1995.21050917.x. J Adv Nurs. 1995. PMID: 7541407

5

The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.

Gardulf A, Björvell H, Gustafson R, Hammarström L, Smith CI. Gardulf A, et al. Clin Exp Immunol. 1993 May;92(2):200-4. doi: 10.1111/j.1365-2249.1993.tb03380.x. Clin Exp Immunol. 1993. PMID: 7683584 Free PMC article.

6

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.

Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Jacobsen MB, Jonsson E, Möller G, et al. Gardulf A, et al. Lancet. 1995 Feb 11;345(8946):365-9. doi: 10.1016/s0140-6736(95)90346-1. Lancet. 1995. PMID: 7845120 Clinical Trial.

7

Prophylactic therapy for selective IgA deficiency.

Gustafson R, Gardulf A, Granert C, Hansen S, Hammarström L. Gustafson R, et al. Among authors: gardulf a. Lancet. 1997 Sep 20;350(9081):865. doi: 10.1016/S0140-6736(05)62034-X. Lancet. 1997. PMID: 9310611 No abstract available.

8

Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women.

Gardulf A, Andersson E, Lindqvist M, Hansen S, Gustafson R. Gardulf A, et al. J Clin Immunol. 2001 Mar;21(2):150-4. doi: 10.1023/a:1011051704960. J Clin Immunol. 2001. PMID: 11332654

9

Express subcutaneous IgG infusions: decreased time of delivery with maintained safety.

Hansen S, Gustafson R, Smith CI, Gardulf A. Hansen S, et al. Among authors: gardulf a. Clin Immunol. 2002 Sep;104(3):237-41. doi: 10.1006/clim.2002.5215. Clin Immunol. 2002. PMID: 12217333

10

Women with primary antibody deficiencies requiring IgG replacement therapy: their perception of prenatal care during pregnancy.

Hansen S, Gardulf A, Andersson E, Lindqvist M, Gustafson R. Hansen S, et al. Among authors: gardulf a. J Obstet Gynecol Neonatal Nurs. 2004 Sep-Oct;33(5):604-9. doi: 10.1177/0884217504269010. J Obstet Gynecol Neonatal Nurs. 2004. PMID: 15495706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters